Sort
172,184 grants matching “inflammation”
Mechanisms of Immune Activation and Disease Progression in Animal Models
$3,000,084Jason Brenchley · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Nonclinical Studies to Advance Novel Drug for Post-STEMI Cardiac Regeneration
$3,000,000Hynda Karen Kleinman · Regenerx Biopharmaceuticals, Inc. · RC3 · FY2010 · HL
Rare variants and NHLBI traits in deeply phenotyped cohorts
$3,000,000Bruce M Psaty · University Of Washington · R01 · FY2016 · HL
Commercialization of iSONEP, a Humanized Monoclonal Antibody Against the Bioactiv
$3,000,000Roger Allen Sabbadini · Lpath Therapeutics, Inc. · RC3 · FY2010 · EY
Scientific Information Management and Literature-Based Evaluations for the National Toxicology Program (NTP) â Support for the conduct of Systematic Reviews
$3,000,000David Burch · Icf, Inc., Llc · N01 · FY2019 · ES
Laboratories for Institute for Engineered Interfaces
$3,000,000Kurt H Becker · Polytechnic University Of New York · · FY2010 · O/D
The Role of the Gut Microbiota in Ulcerative Colitis
$3,000,000Vincent B Young · University Of Michigan At Ann Arbor · UH3 · FY2010 · DK
Maternal microbial exposure fundamentally shapes the CD8 T cell population at the maternal fetal interface
$2,999,774Nathan Schuldt · University Of Minnesota · R01 · FY2025 · AI
Development of a Novel Chemokine Receptor Antagonist Peptide as a Non-Opioid Treatment for Relief of Chronic Pain
$2,999,505Michael R Ruff · Creative Bio-Peptides, Inc. · R44 · FY2021 · NS
Finding Genes for Cancer Susceptibility and Growth Regulation
$2,998,700Elaine Ostrander · National Human Genome Research Institute · ZIA · FY2011 · HG
NEW HORIZONS IN THE PREVENTION AND TREATMENT OF FOOD ALLERGY
$2,998,654Robert A Wood · Johns Hopkins University · UM2 · FY2022 · AI
Immune Regulation In Toxoplasmosis And Other Opportunistic Infections
$2,998,583Alan Sher · Niaid Extramural Activities · Z01 · FY2007 · AI
Imaging Probe Development Center
$2,998,424Gary Leonard Griffiths · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
Imaging Probe Development Center
$2,997,882Gary Leonard Griffiths · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
MIND Diet Intervention to Prevent Alzheimer's Disease
$2,997,666Martha C. Morris · Rush University Medical Center · R01 · FY2017 · AG
MINIMALLY-INVASIVE NANO-DIALYSIS NEURAL PROBE FOR MULTIPLEXED MONITORING OF NEUROCHEMICALS WITH HIGH SPATIO-TEMPORAL RESOLUTION
$2,995,311Yurii Vlasov · University Of Illinois At Urbana-Champaign · UF1 · FY2018 · NS
Microbiota and Allergic Asthma Precision Prevention (MAAP2)
$2,994,595Christine C Johnson · Henry Ford Health System · P01 · FY2022 · AI
Age-dependent activation of microglia inflammatory state and its epigenetic modulation
$2,994,272Anne Schaefer · Icahn School Of Medicine At Mount Sinai · RF1 · FY2020 · AG
Environmental Influences on Child Health Outcomes in Puerto Rico (ECHO-PRO)
$2,992,695Akram N Alshawabkeh · Northeastern University · UH3 · FY2019 · OD
Biology of the Prostate Cancer Prevention Trial (PCPT)
$2,991,992Scott M Lippman · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA
Vascular Inflammation and Exosomes as Mediators in Aging and Dementia
$2,991,750Anne A Knowlton · University Of California At Davis · RF1 · FY2018 · AG
Chemoprophylaxis for HIV Prevention in Men
$2,986,662Robert M. Grant · J. David Gladstone Institutes · U01 · FY2006 · AI
Development of Complement Modulating Therapeutics for AMD
$2,986,452Gregory S Hageman · University Of Utah · R24 · FY2010 · EY
Clinical Evaluation of PET Radiotracers
$2,981,746Robert Innis · National Institute Of Mental Health · ZIA · FY2011 · MH
Impact of Asymptomatic CMV on Cardiovascular Event Risk in Treated HIV
$2,981,544Peter W Hunt · University Of California, San Francisco · R01 · FY2025 · HL